APPLICATION
ANDA074498
TYPE
ANDA
ORIGINAL APPROVAL
1996-10-31
LATEST ACTION
2001-08-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
INDAPAMIDEDiscontinued
INDAPAMIDE 1.25MG · TABLET · ORAL
INDAPAMIDEDiscontinued
INDAPAMIDE 2.5MG · TABLET · ORAL
Approval history
2001-08-30Manufacturing (CMC) · Supplement 8AP
2001-06-18Labeling · Supplement 7AP
2000-07-07Manufacturing (CMC) · Supplement 6AP
1998-03-09Manufacturing (CMC) · Supplement 5AP
1998-02-12Manufacturing (CMC) · Supplement 2AP
1998-02-12Labeling · Supplement 3AP
1997-08-04Manufacturing (CMC) · Supplement 4AP
1997-06-11Manufacturing (CMC) · Supplement 1AP
1996-10-31OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.